Home - Company - Seagen

Seagen

Address : 21823 30th Drive Southeast, Bothell, Washington 98021, United States

Phone Number : +1-425-527-4000

Industries : Research, Biotechnology

Website : seagen.com

Company Description

Seagen logo

Targeting Cancer. Transforming Therapies. Seagen is where revolutionary science meets transformative cancer therapy. Seagen is committed to advancing late-stage clinical trials and expanding the development of its portfolio both in and outside the U.S. to better the health of people with cancer. We are dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. We are focused on discovering, developing, manufacturing and commercializing targeted cancer therapeutics, with antibody-drug conjugates (ADCs) at our core. We work together with urgency to improve and extend the lives of people living with cancer.Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients. ADCs are an integral part of the evolving cancer treatment paradigm with their specificity, stability, and potency. We are working on expanding the four approved therapies for cancer while advancing new technologies with the potential to generate multiple Investigational New Drug Applications (INDs) that include next-generation ADC technologies and other novel cancer-targeting approaches.

Specialities

  • Antibodydrug Conjugates
  • Monoclonal Antibodybased Therapies For Cancer
  • Drug Development
  • Bladder Cancer
  • Nonhodgkin Lymphoma
  • Biotechnology
  • Life Sciences
  • Biotechnology: Biological Products (no Diagnostic Substances)
  • Biotechnology Research
  • Hospital & Health Care
  • Conjugation Chemistry
  • Cancer Drug Development
  • Blood Cancers
  • Hodgkin Lymphoma
  • Healthcare
  • Pharmaceuticals
  • Research
  • Health Care
  • Health, Wellness & Fitness
  • Medical

Financial

Employees Total : 4,000

Revenue (Yearly) : 2.3B

Total Funding : 70.5M

Latest Funding : 10M

Public Company : Yes

Trade Symbol : SGEN

Trade Exchange : Nasdaq

Market Cap : 2.3B

Miscellaneous

Founded in : 1998

Twitter : Oncothyreonnews

Facebook : pages/Oncothyreon/158571200837252

Linkedin : seagen

Angellist : angel.co/oncothyreon

Email Providers : Outlook

Hosting : Microsoft Azure Hosting

CMS : Drupal

Recruitment : Taleo

Analytics and Tracking : Google Analytics

Tech : Google Maps

Last Updated : 2023-12-18

Jobs Vacancies

Quality Control Analyst II Sample Management
Bothell, Washington, United States
Posted at : 2023-12-13

Quality Control Analyst II
Bothell, Washington, United States
Posted at : 2023-12-12

Quality Control Analyst I
Bothell, Washington, United States
Posted at : 2023-12-12

Senior Quality Control Analyst
Bothell, Washington, United States
Posted at : 2023-12-12

Employees

Alumni

Competitors

You Might Be Interested With:

Kappa Psi Pharmaceutical Fraternity logo Kappa Psi Pharmaceutical Fraternity
Richardson, Texas, United States
Executive Office
Celgene logo Celgene
Summit, New Jersey, United States
Pharmaceuticals
MHN logo MHN
Dallas, Texas, United States
Market Research
Gorman Learning Center logo Gorman Learning Center
Redlands, California, United States
Government Administration
Pathward logo Pathward
Sioux Falls, South Dakota, United States
Financial Services
FOUCHE NICOLAS logo FOUCHE NICOLAS
Mieussy, Auvergne-Rhône-Alpes, France
Management Consulting
Copyright © 2023 - 2024
CPDatabase.com | About Us | Privacy Policy | Do Not Sell My Personal Info